Emcure Pharmaceuticals Limited together with its subsidiary Gennova Biopharmaceuticals Limited has announced the signing of a 22.78 MWp DC solar power purchase Agreement (PPA) with Sunsure Energy.
Through this partnership, Emcure and Gennova will receive approximately 36 million units of clean, renewable energy annually for their Pune plants. The partnership will significantly advance their sustainability initiatives by meeting around 67 per cent of their power requirements for these plants with green power and offsetting 29,765.71 metric tonnes of CO2 emission annually. Pursuant to the PPA, Emcure and Gennova have signed a shareholders agreement to acquire stake in Sunsure Solarpark Twelve Private Limited, for the purchase of solar power under a group captive scheme.
